SILENCE THERAPEUTICS PLC SLN
ADS · ADR · CUSIP 82686Q101
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersLondon, United Kingdom
- Founded1994
- Websitesilence-therapeutics.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $11.26.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2020 | 3 |
| Q4 2020 | 4 |
| Q1 2021 | 7 |
| Q2 2021 | 7 |
| Q3 2021 | 8 |
| Q4 2021 | 23 |
| Q1 2022 | 27 |
| Q2 2022 | 26 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2020 | 1 | 0 |
| Q1 2021 | 6 | 1 |
| Q2 2021 | 0 | 3 |
| Q3 2021 | 3 | 2 |
| Q4 2021 | 19 | 0 |
| Q1 2022 | 11 | 9 |
| Q2 2022 | 10 | 12 |
Biggest buyers
| Lombard Odier Asset Management (USA) Corp | Added | +134.1k |
| CANTOR FITZGERALD, L. P. | Added | +37.7k |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | New | +28.8k |
| Parkman Healthcare Partners LLC | New | +26.2k |
| WS MANAGEMENT LLLP | New | +25.0k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Added | +15.0k |
| CITADEL ADVISORS LLC | New | +11.4k |
| MORGAN STANLEY | Added | +1.6k |
| SG Americas Securities, LLC | Added | +8 |
| Tower Research Capital LLC (TRC) | Added | +3 |
Biggest sellers
| Lombard Odier Asset Management (Europe) Ltd | Sold out | -1.6m |
| GOLDMAN SACHS GROUP INC | Reduced | -305.8k |
| Altium Capital Management LLC | Sold out | -109.0k |
| GREAT POINT PARTNERS LLC | Reduced | -43.0k |
| AXA S.A. | Reduced | -40.0k |
| Consonance Capital Management LP | Reduced | -19.8k |
| Bellevue Group AG | Reduced | -16.2k |
| Legal & General Group Plc | Sold out | -15.0k |
| BLAIR WILLIAM & CO/IL | Reduced | -5.0k |
| BANK OF AMERICA CORP /DE/ | Sold out | -770 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Griffiths Richard Ian 13D · may seek influence -13.7 pts · filed 2026-08-13 | 8.0% |
| Invus Global Management, LLC 13G · passive investor filed 2026-08-13 | 7.0% |
| Tetragon Financial Management LP 13G · passive investor +0.1 pts · filed 2026-10-13 | 5.3% |
Fell to 5% or below in the last year: Lombard Odier Asset Management (USA) Corp (4.2%, 2026-02-09)
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2022.
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Lombard Odier Asset Management (USA) Corp 8.01% of their portfolio | 3.8m $38.2m | Added +134.1k |
| AXA S.A. 0.03% of their portfolio | 1.3m $15.2m | Reduced -40.0k |
| Deep Track Capital, LP 0.78% of their portfolio | 951.6k $11.3m | Unchanged |
| Frazier Life Sciences Management, L.P. 0.99% of their portfolio | 881.2k $10.4m | Unchanged |
| BVF INC/IL 0.38% of their portfolio | 666.7k $7.9m | Unchanged |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 660.0k $7.8m | Reduced -305.8k |
| Consonance Capital Management LP 31.70% of their portfolio | 634.3k $7.5m | Reduced -19.8k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.02% of their portfolio | 565.0k $6.7m | Added +15.0k |
| GREAT POINT PARTNERS LLC 1.23% of their portfolio | 401.4k $4.8m | Reduced -43.0k |
| Point72 Asset Management, L.P. 0.01% of their portfolio | 250.0k $3.0m | Unchanged |
| CANTOR FITZGERALD, L. P. 0.05% of their portfolio | 211.5k $2.5m | Added +37.7k |
| HSBC HOLDINGS PLC 0.00% of their portfolio | 177.8k $2.1m | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 153.3k $1.8m | Added +1.6k |
| SG Americas Securities, LLC 0.02% of their portfolio | 101.5k $1.2m | Added +8 |
| UBS Group AG 0.00% of their portfolio | 69.3k $821.0k | Reduced -113 |
| CITIGROUP INC 0.00% of their portfolio | 58.3k $691.0k | Unchanged |
| BLAIR WILLIAM & CO/IL 0.00% of their portfolio | 51.2k $606.0k | Reduced -5.0k |
| Bellevue Group AG 0.01% of their portfolio | 30.5k $361.0k | Reduced -16.2k |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 0.00% of their portfolio | 28.8k $341.0k | New |
| Parkman Healthcare Partners LLC 0.11% of their portfolio | 26.2k $311.0k | New |
| WS MANAGEMENT LLLP 0.04% of their portfolio | 25.0k $296.0k | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 11.4k $136.0k | New |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 4.0k $47.0k | Unchanged |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 120 $1.0k | Added +3 |
| Steward Partners Investment Advisory, LLC 0.00% of their portfolio | 100 $1.0k | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |